5-Bromo-4-methyl-2-(methylsulfonyl)pyridine

Catalog No. :
ACOSGL820
CAS No. :
1279106-02-3
Molecular Formula :
C7H8BrNO2S
Molecular Weight :
250.12

IUPAC Name:5-bromo-4-methyl-2-(methylsulfonyl)pyridine

5-Bromo-4-methyl-2-(methylsulfonyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$106.00Login to see priceIn stockInquiry
250mg95%$191.00Login to see priceIn stockInquiry
1g95%$490.00Login to see priceIn stockInquiry
5g95%$1336.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-4-methyl-2-(methylsulfonyl)pyridine
IUPAC Name5-bromo-4-methyl-2-(methylsulfonyl)pyridine
MDL No.MFCD28397882
Molecular FormulaC7H8BrNO2S
Molecular Weight250.12
SMILESO=S(C1=NC=C(Br)C(C)=C1)(C)=O
InChI KeyQRUHXFFHUQCWGD-UHFFFAOYSA-N
Synonym5-bromo-2-methanesulfonyl-4-methyl-pyridine;5-broMo-4-Methyl-2-(Methylsulfonyl)pyridine;5-Bromo-4-methyl-2-(methylsulphonyl)pyridine;Pyridine, 5-bromo-4-methyl-2-(methylsulfonyl)-
CAS No.1279106-02-3
PubChem CID58200664

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOSGL820 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVYUA568 route compound structure diagram
    ACVYUA568778611-64-6 In Stock
  2. Then
  3. ACOSGL820 route product structure diagram
    ACOSGL8201279106-02-3 In Stock
Inquiry

2. ACOSGL820 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWRYF682 route compound structure diagram
    ACWRYF682247135-44-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOSGL820 route product structure diagram
    ACOSGL8201279106-02-3 In Stock
Inquiry

Comments (0)